EmaxHealth

Health knowledge and news provided by doctors.

Ads by Google

Disease and Condition

New Drug based Improves Treatment Of Dangerous Blood Disorder

Novel drug romiplostim significantly improved platelet levels in patients with chronic immune thrombocytopenic purpura - blood disorder.

Two clinical trials of the novel drug romiplostim (Nplate) show that it significantly improved platelet levels in patients with chronic immune thrombocytopenic purpura (ITP), a hematologic disorder that can cause uncontrolled bleeding. An international research team reports Phase 3 trial results for the drug, which duplicates the action of a natural hormone discovered by a Massachusetts General Hospital (MGH) investigator, in the February 2 issue of The Lancet.

Pages